Abstract: The respiratory disease pulmonary fibrosis (PF), which is characterized by scar formation throughout the lung, imposes a serious health burden. No effective drug without side effects has been proven to prevent this fatal lung disease. In this context, this study was undertaken to elucidate the protective effect of celastrol, a quinine methide pentacyclic triterpenoid from a Chinese medicinal plant 'thunder god vine' against bleomycin (BLM)-induced PF. We also attempted to study how the cytokine transforming growth factor-b (TGF-b) stimulates fibrosis through the induction of epithelial-mesenchymal transition (EMT) and the role of celastrol in regulating EMT. TGF-b (5 ng/ml) was administered to human alveolar epithelial adenocarcinoma A549 cells to induce fibrotic response in cells. Induction of EMT was analysed in cells through morphological analysis and expression of epithelial and mesenchymal markers by Western blotting. Bleomycin at a concentration of 3 U/Kg b.w was used to induce fibrosis in adult male rat lungs. Celastrol (5 mg/kg b.w) was given to rats twice a week after BLM administration for a period of 28 days. Western blot and immunofluorescence analyses were performed with lung tissue sample to find out the potential of celastrol in regulating EMT during the progression of fibrosis. TGF-b induces EMT in A549 cells as demonstrated by changes in epithelial cell morphology and expression of epithelial and mesenchymal marker proteins. The expressions of epithelial marker proteins E-cadherin and claudin were found to be reduced in the BLM-induced group of rats. Expression of mesenchymal markers, such as N-cadherin, snail, slug, vimentin and b-catenin, was enhanced in BLM-induced rat lungs. Celastrol reverts these cellular changes in rat lungs, and it was found that celastrol regulates EMT through the inhibition of heat shock protein 90 (HSP 90). Together, the results indicate that EMT is a crucial phenomenon for the progression of fibrosis, and celastrol provides protection against PF through the regulation of EMT.
Idiopathic pulmonary fibrosis (IPF) or pulmonary fibrosis (PF) is a grave lung disease with unknown aetiology, characterized by alternate scar tissues in the lung architecture that lead to interruption in gas exchange function, lung failure and finally death of organism [1] . The pathophysiology of IPF is believed as a result of repeated injury to the alveolar epithelial cells with abnormal wound repair machinery [2] . It has been proven that, whatsoever the signalling cascades that leads to fibrosis, the ultimate product of all such events is the massive accumulation of interstitial collagen which results in scar formation and tissue fibrosis [3] [4] [5] . Activation and proliferation of fibroblasts are greatly influenced by collagen fibres probably through the stimulation of growth factor receptor signalling [6] . In this context, transforming growth factor-beta (TGF-b) signalling gains much attention as it is one of the predominant signalling pathways which leads to organ fibrosis [7, 8] . The cytokine TGF-b is reported as a single growth factor that has the ability to stimulate the necessary fibrotic machinery to induce fibrogenesis in animals [9] . Although other cytokines are also found to be associated with lung fibrogenesis, the effects or changes induced by such cytokines are reversible [10] . Bonniaud et al. [11] have reported that IL-1b independently induces lung fibrosis in mice through stimulation of TGF-b1 signalling pathway.
Other investigators have also reported the role of inflammatory cytokines in stimulating TGF-b-mediated fibrosis [12] . Activation and transphosphorylation of serine-threonine receptors by TGF-b ligand initiate the canonical pathway, which is Smaddependent [13, 14] . Translocation of Smad proteins to the nucleus induces the activation of pro-inflammatory and fibrogenic mediators that activates fibrotic machinery in the organ [15] . The inflammatory cells produced in response to TGF-b, further induces epithelial cell injury and these cascades of events result in extracellular matrix (ECM) degradation and tissue scar formation [16, 17] . Several recent studies suggest that targeting the TGF signalling reduces the extent of PF in experimental models [18, 19] .
During organ fibrosis, the imaging of fibrotic lung reveals a noteworthy change in the epithelium, especially in type I and II alveolar epithelial cells (AECs). It is reported that regeneration of AECs and re-epithelialization are the foremost phenomenon during repair process after lung injury [20] . One important mechanism that facilitates fibroblast proliferation and organ fibrosis is epithelial-mesenchymal transition (EMT) where epithelial cells lose their characteristics and reach the phenotypical features of a mesenchymal cell [21, 22] . Epithelial cells are closely connected with each other through tight junction strands where integral plasma membrane proteins occludin and claudin are important components. The cytoplasmic proteins zonula occludens (ZO) along with actin filaments contribute with strength and integrity of tight junctions. Upon any external or internal stimulation, the initial events take place during EMT is the disassembly and redistribution of these tight junction proteins which results in cytoskeleton reorganization [23, 24] . Along with tight junction proteins, cell adhesion molecules such as E-cadherin are also important in maintaining cytoskeletal structure [25, 26] . Cytoskeletal reorganization facilitates the expression of mesenchymal proteins such as N-cadherin, vimentin and a-smooth muscle actin (a-SMA) and further stimulates the production of ECM proteins such as fibronectins and collagens [27, 28] . EMT can be induced or regulated by various growth and differentiation factors. Among these, TGF-b has gained much attention as a major inducer of EMT during embryogenesis, cancer progression and fibrosis [29, 30] . Bleomycin (BLM)-induced EMT in pleural mesothelial cells that contribute to subpleural fibrosis has previously been reported [31] . Recently, a research group reported that sorafenib ameliorates BLM-induced PF by regulating EMT markers [32] .
Prevalence of PF as well as inefficiency of current drug therapy highly demands to identify new drugs for the treatment of PF. In this context, we have previously reported the ability of celastrol, a triterpenoid derived from the Chinese medicinal plant Tripterygium wilfordii in regulating inflammation and collagen accumulation against BLM-induced experimental PF in rats [33] . Further, we have reported that the protective role of celastrol was found to be associated with the induction of autophagy through the degradation of p62/SQSTM1 that links Nrf2 signalling and autophagy [34] . As epithelial cells are the major targets during BLM-induced lung injury, we were curious to know the capacity of epithelial cells to react to the environmental changes by undergoing EMT. The potential of celastrol in regulating the expression of transcription factor snail and cell adhesion molecule E-cadherin during cancer progression is reported [35] . However, its role in regulating EMT during PF remains unclear. In this context, this study highlights the crucial involvement of EMT during the progression of BLM-induced PF and the potential role of celastrol in regulating the pathomechanisms of EMT to provide protection against PF. The rats were divided into four groups. Each group contained six rats. Group 1: Control rats received DMSO only. Group 2: Rats administered with single intratracheal instillation of BLM (3 U/kg b.w.). Group 3: BLM-induced rats treated with celastrol (5 mg/kg b.w) twice a week [33, 34] . Group 4: Rats treated with celastrol alone (5 mg/kg b.w) twice a week.
Materials and Methods
After 28 days, all the animals were killed by cervical decapitation and lung tissue was quickly excised and processed for further experiments.
Immunofluorescence analysis. The sections were de-paraffinized in xylene and were treated with decreasing concentration of ethanol solution for rehydration. The sections were allowed to drained off the excess solution and incubated with primary antibodies for TGF-b1 (1:500), pSmad 2/3 (1:500), E-cadherin (1:1000) and HSP-90 (1:1000) at 4°C overnight. The sections were washed well with Tris-buffered saline (TBS) and incubated with respective secondary antibodies for 2 hr in dark at room temperature. The tissue sections were counter-stained with respective stains, and the fluorescence images were captured.
Confocal microscopic analysis of b-catenin. Four micrometer thick lung tissue sections were processed as described above. The tissue sections were incubated with primary antibody specific for b-catenin (1:500) for overnight at 4°C. After washing with TBS, the sections were incubated with TRITC-conjugated secondary antibody for 2 hr at room temperature in dark. Finally, the sections were counter-stained with Hoechst 33342, and the images were taken in a confocal laser scanning microscope (TCS-SP2-XL, Leica, Wetzlar, Germany).
Western blot analysis. After treatment with TGF-b1 and celastrol, A549 cells were harvested by trypsinization. Cells were lysed with cell lysis buffer containing 150 mM NaCl, 5 mM ethylenediaminetetraacetic acid (EDTA), 50 mM Tris-Cl and 1% Triton X-100. Cells were scraped out, and the cell lysate was centrifuged at 8,944 g for 15 min. at 4°C. The protein content of the supernatant was determined by CB-X TM protein assay kit (G-Biosciences, St. Louis, USA). Forty microgram of protein per well was mixed with 29 sample buffer and denatured at 95°C for 5 min. and loaded into the wells. For the lung tissue sample of denatured lung tissue protein samples was loaded into each well, and proteins were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were transferred to a nitrocellulose membrane (Pierce; Thermo Fisher Scientific). The membranes were blocked with blocking buffer containing 5% non-fat dried milk in TBS/Tween for 2 hr at room temperature. The membranes were incubated with primary antibodies specific for TGF-b1 Statistical analysis. SPSS/10.0 software, IBM corporation, New York, USA, was used to analyse the data. One-way analysis of variance (ANOVA) followed by least significant difference (LSD) was performed to find out the statistical significance at p < 0.05. Each group contained six rats; each experiment was performed in triplicate, and the results were expressed as mean AE S.D.
Results
TGF-b1 plays a key role in lung fibrogenesis. In this study, we analysed the expression of TGF-b1 in lung tissue sections of control and experimental groups of rats by immunofluorescence and Western blotting. The results are depicted in fig. 1A and B, respectively. In the sections of BLM instillation, an increase in the expression of TGF-b1 was observed when compared to the control group ( fig. 1A ). Upon treatment with celastrol to BLM-induced rats, a significant decrease in the expression of TGF-b1 was observed. fig. 1B, lane 3) . TGFb1 protein was observed in the lung tissue of control and celastrol alone-treated group to a negligible extent only.
Celastrol reduces the expression of Smad 2/3 upon TGF-b1-induced fibrotic response. Although TGF-b1 possesses a foremost role in fibrogenesis, its effectors Smad proteins exert distinct functions in the progression of fibrosis [36] . As we observed an abundant expression of TGF-b1 in BLM-induced rat lungs, we analysed the expression of p-Smad 2/3 by immunofluorescence and Western blot analysis to study the effect of Smad protein in BLM-induced fibrosis. Fig. 2A represents the expression of p-Smad as evaluated by fluorescence microscopy. A significant increase in the expression of p-Smad was observed in the lung tissue section of the BLM-induced group of rats in accordance with previous reports [37, 38] . Celastrol reduces its expression, and much difference was not observed between the lung tissues of control and celastrol alone-treated group of rats. Western blot analysis of p-Smad 2/3 is depicted in fig. 2B , and the results correlate with the immunostaining analysis. In the BLM-induced group, increased expression of Smad protein was observed when compared with control. Celastrol could decrease the expression of p-Smad by half-fold. To identify the possible mechanism behind the fibrotic response induced by TGF-b1 in lungs, we investigated the involvement of epithelial-to-mesenchymal transition (EMT) pathway in the progression of PF.
TGF-b1 induces alveolar epithelial cells to undergo EMT.
The important characteristic features of alveolar type II A549 cells make it a valuable tool to study EMT in several experimental conditions [39, 40] . We conducted a pilot study to fix the optimum dosage of TGF-b1 to induce fibrotic response in A549 cells. We found that of 2, 5 and 10 ng/ml concentrations of TGF-b1, 5 ng/ml TGF-b1 elicited clear morphological changes in A549 cells (data not shown). As the lower dose of TGF-b1 (2 ng/ml) did not elicit much appreciable change and higher dose of TGF-b1 (10 ng/ml) was found to be harsh to the cells, the concentration of TGF-b1 as 5 ng/ml was fixed for this study. Further, the effect of celastrol on the viability of A549 cells was analysed by 3-(4,5-di-methylthiazol-2-yl)-2,5-di-phenyltetrazolium bromide (MTT) assay. Celastrol at a concentration of 1-10 lM for 0-12 hr did not cause any noticeable decline in viability. However, a significant loss in viability of A549 cells was observed from 12 to 24 hr in a dose-dependent manner. Further, it was observed that celastrol at a concentration of 5 lM was found to be ideal as it possesses minimal toxicity to the cells. Fig. 3A represents the morphological changes induced by TGF-b1 in A549 cells. Untreated A549 cells show a pebble-like shape of epithelial cells, and cell-cell adhesion is clearly observed. TGF-b1-differentiated cells show a decrease in cellcell contacts and adopt a more elongated spindle shape morphological features of a mesenchymal cell. Morphological changes occurred in A549 cells upon administration with TGF-b1 indicates that TGF-b1 induces EMT in A549 cells. In addition, we have analysed the expression of epithelial markers E-cadherin and ZO-1 and mesenchymal cell markers, N-cadherin, vimentin, snail and slug in TGF-b1-induced A549 cells by Western blot analysis ( fig. 3B ). TGF-b1 administered A549 cells exhibited decreased expressions of epithelial markers E-cadherin and ZO-1. Interestingly, celastrol-treated cells showed increased expressions of these epithelial markers when compared with TGF-b1-induced cells. Further, the expressions of mesenchymal marker N-cadherin and transcription factors, snail and slug were high in TGF-b1-induced cells. Treatment with celastrol tremendously decreased the expressions of these mesenchymal markers in TGF-b1-induced A549 cells. However, much significant difference in the expression of vimentin between experimental set of cells was not observed.
Involvement of EMT in bleomycin-induced pulmonary fibrosis.
The in vitro results obtained motivated us to further investigate the involvement of EMT in BLM-injured rat lungs. We performed these experiments with the aim to rule out whether celastrol possesses any property to regulate EMT pathway in BLM-induced PF which is nowhere reported. We analysed the expression of epithelial cell markers E-cadherin and claudin by immunofluorescence and Western blot analysis in control and experimental groups of rats. Fig. 4A represents the immunofluorescence analysis of E-cadherin, and fig. 4B represents the Western blot analysis of E-cadherin and claudin. Administration of BLM in rat lungs resulted in a significant decrease in the expression of E-cadherin and claudin. In celastrol-treated rats, the loss of E-cadherin and claudin expressions in the alveolar epithelium was reversed. Western blot analysis of mesenchymal markers such as N-cadherin, snail, slug and vimentin in lung tissue of control and experimental groups of rats is depicted in fig. 5 . BLM-injured rat lungs exhibited increased expressions of N-cadherin, snail and slug. Celastrol treatment significantly reduced the expressions of these mesenchymal markers. In consistent with data obtained from in vitro studies, there was not much significant difference in the expression of vimentin among experimental rat lungs. Celastrol inhibit b-catenin and regulate induction of EMT. Fig. 6A represents the confocal imaging of lung tissue of the control and experimental groups of rats. BLM-injured rat lungs exhibited increased expression of b-catenin. Celastrol treatment in BLM-induced rats tremendously decreased its expression. Western blot analysis further confirmed the results ( fig. 6B) . A significant descend in the expression of b-catenin was observed in celastrol-treated rat lungs when compared with BLM-induced rat lungs. The observed expression of bcatenin in BLM-induced rat lungs strongly supports the active involvement of EMT in the progression of PF.
Celastrol regulates EMT through the inhibition of heat shock protein 90 (HSP90).
Tissue sections of BLM-induced rat lungs exhibited abundant expression of HSP90 when compared with control rat lungs. Celastrol-treated rat lungs exhibited half the fold decrease in the expression of HSP90. Celastrol alone-treated rat lungs also exhibited negligible expression of HSP90 ( fig. 7 ).
Discussion
The current study was aimed to identify the involvement of TGF-b-mediated EMT in the progression of BLM-induced PF in rats and the ability of celastrol in modulating the cellular changes induced by BLM in rat lungs.
It is known that TGF-b1 increases the generation of free radicals such as reactive oxygen species and reactive nitrogen species in lung fibroblasts [41] . It has been reported that during BLM injury, TGF-b1 mRNA expression increases predominantly in various cells such as alveolar macrophages, fibroblasts, endothelial cells and mesothelial cells [42, 43] . In accordance with these reports, the result of our study shows a pronounced expression of TGF-b1 in lung tissue sections of rats induced with BLM. Along with TGF-b1, its signal transducer Smad also regulates fibrogenesis in lungs. Upon stimulated by TGF-b1, Smads 2, 3 and 4 induce collagen gene transcription leading to accumulation of ECM components [44] . This is the first report to show the ability of celastrol in regulating TGF-b1/Smad-mediated fibrogenesis in lungs.
E-cadherin is a calcium-dependent cell adhesion molecule that is present in the plasma membrane of normal epithelial cells. During EMT, E-cadherin is cleaved by proteases. Therefore, down-regulation of E-cadherin is considered a marker for EMT induction [45] . Loss of cell polarity is one of the major features of mesenchymal cells [46] . Decreased expression of epithelial markers E-cadherin and ZO-1 suggests the induction of EMT in A549 cells upon TGF-b1 administration. In addition, the high expression of N-cadherin, which is a mesenchymal protein in A549 alveolar epithelial cell, further confirms the acquisition of mesenchymal features of epithelial cells. The transcription factors snail and slug are reported as a suppressor for E-cadherin. Moreover, E-cadherin functions as a substrate for b-catenin to form cadherin/catenin complex which induces the transcription of mesenchymal proteins [47] . Increased expressions of these mesenchymal markers were observed in TGF-b trans-differentiated A549 cells. Thus, one possible role of TGF-b1 in the progression of PF is to induce or promote epithelial cells in an injured alveolar epithelium to undergo EMT which is in accordance with other investigators [48, 49] . The results of in vitro study support the concept that TGF-b1 can induce alveolar EMT in human lung epithelial cells.
Further, to find out the effect of celastrol in regulating EMT in BLM-induced experimental fibrosis in rats, we analysed the expressions of epithelial and mesenchymal markers in lung tissue of rats. Although the effect of celastrol in regulating the protein expression of E-cadherin has been reported in lung cancer model [35] , the effect of celastrol on the expression of claudin has not been reported. In this study, we show evidence that celastrol prevents the induction of EMT in rat lungs. Ncadherin, vimentin, a-SMA, fibroblast specific protein (FSP)-1 and collagen have provided reliable markers to characterize the mesenchymal products generated by the EMTs that occur during the development of fibrosis in various organs [49, 50] . Along with these, transforming epithelial cells normally show the expression of transcription factors such as snail, twist and slug [51] [52] [53] . In fact, the cadherin switch over from E-cadherin to N-cadherin is a useful tool to monitor the involvement of EMT [54] . In consistent with the data obtained from in vitro studies, we have observed increased expression of mesenchymal markers in lung tissue of BLM-induced rats. The intermediate filament vimentin is a controversial marker of EMT. It is reported that not only mesenchymal cells but adult epithelial cells can also express vimentin in response to several stimuli [55] . In this way, vimentin may not be considered as a marker for type 2 EMT in the context of fibrosis [56] . In accordance with this report, in our study, we also could not observe a significant difference in the expression of vimentin between experimental groups of rats as well as in TGF-b-administered A549 cells.
Transcription factors snail 1 and snail 2 (also known as slug) are the prominent downstream targets of various signalling pathways that regulate EMT. Snail-mediated direct inhibition of E-cadherin [57] and down-regulation of other epithelial markers independent of E-cadherin [58] are well studied. Interestingly, b-catenin, one of the major components of Wnt signalling pathway, is reported as a direct regulator of snail 1 [59] . b-catenin can therefore be used as a marker of EMT in studies of embryonic development, cancer and fibrosis [47, 60] . The celastrol-treated group of rats exhibited significant descend in the expression of b-catenin which was increased in BLM-induced rat lungs. The observed expression of b-catenin in BLM-induced rat lungs strongly supports the active involvement of EMT in the progression of PF.
The direct inhibitions of HSP90 by celastrol has been documented [61, 62, 63] . These reports shed light to our hypothesis that celastrol may regulate EMT via its inhibitory action on HSP90 because this chaperone is directly associated with the down-regulation of E-cadherin [64, 65] . The inhibition in the protein expression of HSP90 by celastrol in BLM-injured rat lungs highlights its potential role in modulating the induction of EMT by BLM. As celastrol is a known inhibitor of HSP90, it can be concluded that one of the mechanisms that celastrol regulates the pathological events in EMT may be through the inhibition of HSP90 which can directly act upon E-cadherin function.
